Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1

By sjmartinez • October 4, 2022

Youn JY, Wang J, Li Q, Huang K, Cai H. Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1. Front Cardiovasc Med. 2022 Sep 15;9:957340. doi: 10.3389/fcvm.2022.957340. PMID: 36187008; PMCID: PMC9520320.

Tags: acute respiratory distress syndrome (ARDS), Cardiology/Epi, covid-19, endothelial dysfunction, NADPH oxidase isoform 2 (NOX2), Publications, SARS-CoV-2

Intravenous ferric carboxymaltose in patients with heart failure and iron deficiency: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis

Ahmed M, Zulfiqar E, Hashmi TM, Zia R, Ashraf H, Naveed MA, Ahmed R, Rana JS, Ahmed F, Greene SJ, Fudim M, Mentz RJ, Fonarow[...]

Coronary artery calcium score of zero in individuals with diabetes: association with normal coronary arteries and cardiovascular risk factors

Phan JP, Kinninger A, Roy SK, Bhandari M, Budoff MJ. Coronary artery calcium score of zero in individuals with diabetes: association with normal coronary arteries[...]

Richard Cheng, MD Appointed Associate Director of Interventional Cardiology

We are pleased to announce the appointment of Richard Cheng, MD as the new associate director of interventional cardiology (IC) in the UCLA Department of Medicine Division of Cardiology. In this capacity, Dr. Cheng will[...]